ES2057475T3 - Procedimiento para la preparacion de concentrado de complejo factor viii-factor de willebrand de la coagulacion sanguinea a partir de plasma total. - Google Patents

Procedimiento para la preparacion de concentrado de complejo factor viii-factor de willebrand de la coagulacion sanguinea a partir de plasma total.

Info

Publication number
ES2057475T3
ES2057475T3 ES90402395T ES90402395T ES2057475T3 ES 2057475 T3 ES2057475 T3 ES 2057475T3 ES 90402395 T ES90402395 T ES 90402395T ES 90402395 T ES90402395 T ES 90402395T ES 2057475 T3 ES2057475 T3 ES 2057475T3
Authority
ES
Spain
Prior art keywords
total plasma
procedure
preparation
blood coagulation
complex concentrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90402395T
Other languages
English (en)
Spanish (es)
Inventor
Miryana Burnouf-Radosevich
Thierry Burnouf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre Regional de Transfusion Sanguine de Lille
Centre Regional de Transfusion Sanguine
Original Assignee
Centre Regional de Transfusion Sanguine de Lille
Centre Regional de Transfusion Sanguine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Regional de Transfusion Sanguine de Lille, Centre Regional de Transfusion Sanguine filed Critical Centre Regional de Transfusion Sanguine de Lille
Application granted granted Critical
Publication of ES2057475T3 publication Critical patent/ES2057475T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
ES90402395T 1989-09-05 1990-08-30 Procedimiento para la preparacion de concentrado de complejo factor viii-factor de willebrand de la coagulacion sanguinea a partir de plasma total. Expired - Lifetime ES2057475T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8911567A FR2651437A1 (fr) 1989-09-05 1989-09-05 Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.

Publications (1)

Publication Number Publication Date
ES2057475T3 true ES2057475T3 (es) 1994-10-16

Family

ID=9385124

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90402395T Expired - Lifetime ES2057475T3 (es) 1989-09-05 1990-08-30 Procedimiento para la preparacion de concentrado de complejo factor viii-factor de willebrand de la coagulacion sanguinea a partir de plasma total.

Country Status (24)

Country Link
US (1) US5679776A (enExample)
EP (1) EP0416983B1 (enExample)
AT (1) ATE91896T1 (enExample)
AU (1) AU627618B2 (enExample)
BR (1) BR9004626A (enExample)
CA (1) CA2024667C (enExample)
CZ (1) CZ277939B6 (enExample)
DD (1) DD298110A5 (enExample)
DE (1) DE69002427T2 (enExample)
DK (1) DK0416983T3 (enExample)
ES (1) ES2057475T3 (enExample)
FI (1) FI95654C (enExample)
FR (1) FR2651437A1 (enExample)
HR (1) HRP920768B1 (enExample)
HU (1) HU206378B (enExample)
LT (1) LT3418B (enExample)
LV (1) LV10053B (enExample)
NO (1) NO178716C (enExample)
PL (1) PL164754B1 (enExample)
RU (1) RU2025129C1 (enExample)
SI (1) SI9012034B (enExample)
SK (1) SK279367B6 (enExample)
UA (1) UA26847C2 (enExample)
YU (1) YU48356B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3904354A1 (de) * 1989-02-14 1990-08-16 Behringwerke Ag Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung
ES2042138T3 (es) * 1989-05-24 1993-12-01 Miles Inc. Filtracion en gel del factor viii tratado termicamente.
AT403991B (de) * 1990-04-04 1998-07-27 Atomic Austria Gmbh Alpinschi
AT403992B (de) * 1991-02-22 1998-07-27 Head Sport Ag Ski
DE4204694C3 (de) * 1992-02-01 1995-10-12 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem Faktor VIII mittels Anionenaustauscher-Chromatographie
IT1256622B (it) * 1992-12-04 1995-12-12 Sclavo Spa Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii:c-fvw) da plasma umano totale.
DE4430205A1 (de) * 1994-08-26 1996-02-29 Behringwerke Ag Zusammensetzungen, die als Gegenmittel für Blut-Antikoagulanzien geeignet sind und deren Verwendung
DE4435485C1 (de) * 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
AT403764B (de) 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
AT403765B (de) 1996-04-12 1998-05-25 Immuno Ag Verfahren zur herstellung einer präparation enthaltend einen hochgereinigten komplex
AT406373B (de) * 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
EP1029546A1 (en) * 1997-11-05 2000-08-23 Yoshitomi Pharmaceutical Industries, Ltd. Heparin cofactor ii preparations and process for producing the same
DE69811628T2 (de) 1998-02-11 2003-12-18 Zlb Bioplasma Ag, Bern Verfahren zur Entfernung von Erregern übertragbarer spongiformer Encephalophatien aus Proteinlösungen
PT2193809E (pt) 1999-02-22 2015-08-24 Baxter Int Formulações de fator viii livres de albumina
DE19937218A1 (de) * 1999-08-06 2001-02-08 Aventis Behring Gmbh Verfahren zur Reindarstellung der den Blutgerinnungsfaktor VII aktivierenden Protease, ihres Proenzyms oder eines Gemisches beider Proteine mittels Affinitätschromatographie
ES2229931B1 (es) * 2003-10-03 2006-01-16 Grifols, S.A. Composicion liquida bilogicamente estable de fviii, de fvw o del complejo fviii/fvw humanos.
RU2253475C1 (ru) * 2004-02-02 2005-06-10 Общество с ограниченной ответственностью "Гемоцентр" Способ получения препарата фактора viii
FR2874216B1 (fr) * 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
BRPI0921429B1 (pt) 2008-11-07 2022-07-12 Takeda Pharmaceutical Company Limited Formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável
US20150080309A1 (en) 2012-04-24 2015-03-19 Nova Nordisk A/S Compounds Suitable for Treatment of Haemophilia
ES2693380T3 (es) 2013-11-08 2018-12-11 Csl Limited Nuevo método para concentrar el factor de von Willebrand o complejos de este
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
CN104231073B (zh) * 2014-09-25 2017-01-25 广东双林生物制药有限公司 一种人凝血因子viii的制备方法
CN105315365A (zh) * 2015-11-17 2016-02-10 上海洲跃生物科技有限公司 一种人抗凝血酶iii的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803115A (en) * 1972-05-17 1974-04-09 Baxter Laboratories Inc Stabilization of ahf using heparin
ES471858A1 (es) * 1977-07-25 1979-02-01 Monsanto Co Un metodo para separar el factor especifico de coagulacion de la sangre de una mezcla con otras proteinas de la sangre en un medio fluido
US4386068A (en) * 1980-02-26 1983-05-31 Cutter Laboratories, Inc. Antihemophilic factor concentrate and method for preparation
US4359463A (en) * 1980-11-26 1982-11-16 Rock Gail A Stabilization of Factor VIII activity in whole blood or blood plasma
US4435318A (en) * 1981-05-22 1984-03-06 Ionics, Incorporated Electrodialysis preparation of purified AHF concentrate
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
US4952675A (en) * 1985-02-01 1990-08-28 New York University Method for purifying antihemophilic factor
FR2632309B1 (fr) 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus

Also Published As

Publication number Publication date
YU203490A (sh) 1993-05-28
SI9012034B (sl) 1999-12-31
EP0416983A1 (fr) 1991-03-13
DD298110A5 (de) 1992-02-06
PL286746A1 (en) 1991-05-06
HU905797D0 (en) 1991-03-28
HRP920768A2 (en) 1995-02-28
CA2024667C (en) 2001-07-31
AU627618B2 (en) 1992-08-27
ATE91896T1 (de) 1993-08-15
SK431290A3 (en) 1998-10-07
EP0416983B1 (fr) 1993-07-28
HUT56858A (en) 1991-10-28
FI904381A0 (fi) 1990-09-05
LT3418B (en) 1995-09-25
HRP920768B1 (en) 1998-12-31
NO903865D0 (no) 1990-09-05
SK279367B6 (sk) 1998-10-07
US5679776A (en) 1997-10-21
FI95654C (fi) 1996-03-11
DE69002427T2 (de) 1993-12-23
AU6221890A (en) 1992-03-12
LV10053B (en) 1995-02-20
DE69002427D1 (de) 1993-09-02
DK0416983T3 (da) 1993-10-04
LTIP263A (en) 1994-10-25
FI95654B (fi) 1995-11-30
LV10053A (lv) 1994-05-10
NO903865L (no) 1991-03-06
PL164754B1 (pl) 1994-10-31
CZ431290A3 (en) 1993-01-13
NO178716B (no) 1996-02-12
CA2024667A1 (en) 1991-03-06
FR2651437B1 (enExample) 1994-08-19
FR2651437A1 (fr) 1991-03-08
SI9012034A (en) 1997-10-31
HU206378B (en) 1992-10-28
BR9004626A (pt) 1992-03-24
NO178716C (no) 1996-05-22
UA26847C2 (uk) 1999-12-29
YU48356B (sh) 1998-07-10
CZ277939B6 (en) 1993-06-16
RU2025129C1 (ru) 1994-12-30

Similar Documents

Publication Publication Date Title
ES2057475T3 (es) Procedimiento para la preparacion de concentrado de complejo factor viii-factor de willebrand de la coagulacion sanguinea a partir de plasma total.
ES2070919T3 (es) Separacion cromatografica de las proteinas del plasma, principalmente del factor viii, del factor de willebrand de la fibronectina y del fibrinogeno.
ES8505405A1 (es) Un procedimiento para producir un activador de plasminogeno purificado.
ES2060033T3 (es) Un procedimiento para preparar un polipeptido de fusion.
ES2108738T3 (es) Procedimiento para la preparacion de un concentrado de trombina humana destinado a un uso terapeutico.
IT8123070A0 (it) Preparato che favorisce la coagulazione del sangue a base di proteine umani, nonche'procedimento per la preparazione
HUT66437A (en) A composition used as a therapeutic agent against chronic viral hepatic diseases
ES2038650T3 (es) Procedimiento para preparar una composicion farmaceutica que comprende 3'-desoxitimidin-2'-eno-(3'-desoxi-2',3'-dideshidrotimidina) para tratar pacientes infectados con retrovirus.
SE396011B (sv) Forfarande for framstellning av en i huvudsak klar, steril vattenlosning av 1,3-bis(2-karboxikromon-5-yloxi)-propan-2-ol eller ett farmaceutiskt godtagbart salt derav
ES2053684T3 (es) Procedimiento para preparar un factor antihemofilico, altamente puro, no infeccioso, mediante cromatografia.
ES8708241A1 (es) Un procedimiento para la preparacion de nuevos compuestos poliprenilicos
ES8402814A1 (es) Un procedimiento de preparacion de derivados de propanol.
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
RU96104214A (ru) Способ лечения транссудативных форм центральных хориоретинальных дистрофий
ES2072431T3 (es) D-acido aspartico beta-hidroxamato para el tratamiento de infecciones virales y de tumores.
EP0429324A3 (en) Use of n-methyl-2-(3-pyridyl)2-tetrahydrothiopyran-carbothioamide-1-oxide for the preparation of medicaments for the treatment of coronary insufficiency
GR3005378T3 (enExample)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 416983

Country of ref document: ES